ArticleFrontiers in immunology2025

Health impact of using anti-PD-(L)1 agents to treat early-stage cancers in Switzerland: a modeling study.

Andrea Favre-Bulle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.